Severe Drug-Induced Agranulocytosis Successfully Treated with Recombinant Human Granulocyte Colony-Stimulating Factor

Table 1

Laboratory data on admission.

WBC	830	/μL	TP	6.1	g/dL
(i) Neutrophil	0.9	%	Alb	2.8	g/dL
(ii) Lymphocyte	50.2	%	T-Bil	0.4	mg/dL
(iii) Basophil	2.2	%	AST	19	U/L
(iv) Eosinophil	1.0	%	ALT	15	U/L
(v) Monocyte	45.8	%	LDH	144	U/L
RBC	345	×10^4/μL	ALP	185	U/L
Hb	10.3	g/dL	γ-GTP	15	U/L
Ht	32.0	%	AMY	63	U/L
Plt	10.2	×10^4/μL	BUN	25.1	mg/dL
CRP	8.14	mg/dL	Cr	0.75	mg/dL
ABGA (O2 10 L/min by reservoir mask)			Na	137	mEq/L
pH	7.390	g/dL	K	4.1	mEq/L
PaCO2	32.5	mmHg	Cl	108	mEq/L
PaO2	125.0	mmHg	Glucose	113	mg/dL
HCO3^−	19.2	mmol/L	PT-INR	1.67	—
SaO2	98.9	%	APTT	44.5	s

WBC: white blood cell; RBC: red blood cell; Hb: hemoglobin; Ht: hematocrit; Plt: platelet; CRP: C-reactive protein; ABGA: arterial blood gas analysis; TP: total protein; Alb: albumin; T-Bil: total bilirubin; AMY: amylase; BUN: blood urea nitrogen; Cr: creatinine; PT-INR: international normalized ratio of prothrombin time; APTT: activated partial thromboplastin time.